Omada Health (NASDAQ:OMDA) CEO Sells $650,696.20 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 40,796 shares of the business’s stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $15.95, for a total transaction of $650,696.20. Following the completion of the transaction, the chief executive officer owned 126,644 shares in the company, valued at $2,019,971.80. This represents a 24.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Omada Health Trading Down 3.9%

NASDAQ OMDA traded down $0.63 during trading hours on Wednesday, reaching $15.50. 865,768 shares of the company traded hands, compared to its average volume of 910,452. The company has a 50 day moving average of $17.22 and a two-hundred day moving average of $20.04. Omada Health, Inc. has a 12 month low of $14.14 and a 12 month high of $28.40. The stock has a market capitalization of $897.57 million and a PE ratio of -62.00.

Analyst Ratings Changes

OMDA has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Barclays decreased their price objective on Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a research report on Monday, January 5th. Morgan Stanley set a $32.00 price target on shares of Omada Health in a report on Thursday, December 18th. Wells Fargo & Company started coverage on Omada Health in a report on Thursday, January 8th. They set an “equal weight” rating and a $17.00 price objective for the company. Finally, Evercore ISI boosted their target price on Omada Health from $27.00 to $28.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Eight analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $25.40.

Hedge Funds Weigh In On Omada Health

Several large investors have recently bought and sold shares of the stock. Sanofi acquired a new stake in Omada Health during the second quarter worth about $9,606,000. Teacher Retirement System of Texas bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $640,000. Jennison Associates LLC acquired a new stake in shares of Omada Health during the 2nd quarter worth approximately $4,580,000. Emerald Advisers LLC bought a new stake in shares of Omada Health during the second quarter valued at approximately $5,089,000. Finally, Emerald Mutual Fund Advisers Trust acquired a new position in shares of Omada Health in the second quarter valued at $2,950,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.